About Ochre Bio
Ochre Bio is a company based in Oxford (United Kingdom) founded in 2019.. Ochre Bio has raised $39.73 million across 3 funding rounds from investors including Khosla Ventures, Lifelink Systems and Backed. The company has 11 employees as of January 31, 2022. Ochre Bio offers products and services including RNA Therapies, Genomic Platform, and Validation Platform. Ochre Bio operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Oxford, United Kingdom
- Employees 11 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ochre Bio Ltd
- Date of Incorporation 04 Nov, 2019
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
-
Net Profit
$-13.63 M (USD)0as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$39.73 M (USD)
in 3 rounds
-
Latest Funding Round
$30 M (USD), Series A
Oct 10, 2022
-
Investors
Khosla Ventures
& 13 more
-
Employee Count
11
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ochre Bio
Ochre Bio offers a comprehensive portfolio of products and services, including RNA Therapies, Genomic Platform, and Validation Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for liver diseases using RNA platforms
Analyzes human liver data for therapy discovery
Tests therapies in human systems for disease validation
Unlock access to complete
Funding Insights of Ochre Bio
Ochre Bio has successfully raised a total of $39.73M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $30.0M
-
First Round
First Round
(18 Mar 2020)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series A - Ochre Bio | Valuation | Khosla Ventures | |
| Jun, 2021 | Amount | Seed - Ochre Bio | Valuation | Khosla Ventures | |
| Mar, 2020 | Amount | Seed - Ochre Bio | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ochre Bio
Ochre Bio has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Khosla Ventures, Lifelink Systems and Backed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm providing seed funding and community support to founders
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments in healthcare and biotech are made.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ochre Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ochre Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ochre Bio Comparisons
Competitors of Ochre Bio
Ochre Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ochre Bio
Frequently Asked Questions about Ochre Bio
When was Ochre Bio founded?
Ochre Bio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Ochre Bio located?
Ochre Bio is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Ochre Bio?
Jack Omeara is the current CEO of Ochre Bio.
Is Ochre Bio a funded company?
Ochre Bio is a funded company, having raised a total of $39.73M across 3 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Mar 18, 2020.
How many employees does Ochre Bio have?
As of Jan 31, 2022, the latest employee count at Ochre Bio is 11.
What does Ochre Bio do?
Founded in 2019 in Oxford, United Kingdom, Ochre Bio operates in the biotechnology sector. Genomic medicines are developed to address liver diseases through gene therapies that identify and inactivate over-active genes. These therapies support liver transplantation and help prevent fatty liver conditions. A genetic atlas of the human liver has been created via sequencing technologies, with algorithms employed to analyze resulting data sets for deeper disease insights.
Who are the top competitors of Ochre Bio?
Ochre Bio's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Ochre Bio offer?
Ochre Bio offers RNA Therapies, Genomic Platform, and Validation Platform.
Who are Ochre Bio's investors?
Ochre Bio has 14 investors. Key investors include Khosla Ventures, Lifelink Systems, Backed, Apollo Health Ventures, and Hoxton Ventures.